Argent shares soar after CannEpil deal wipes out US$5.5m debt by Adam Sheldon July 7, 2026July 7, 2026 Shares in Argent BioPharma more than doubled on the ASX on Tuesday after it struck a […]
Publication aims to plug evidence gap for cannabis and epilepsy by Martin Lane October 29, 2024February 25, 2025
Lennox-Gastaut syndrome becomes second Epidyolex indication to be listed on PBS by Steve Jones June 5, 2023April 30, 2024
Clinical experts publish advice on prescribing medicinal cannabis to patients with epilepsy by Martin Lane March 10, 2022April 29, 2024
Whole-plant cannabis may be more effective than conventional treatment in children with severe epilepsy by Hannah Adler December 17, 2021April 29, 2024
Medical experts defer decision to subsidise CBD epilepsy treatment by Steve Jones August 24, 2020April 22, 2024
